These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 6619033)

  • 61. The new cephalosporins and penicillins.
    Weinstein AJ
    Compr Ther; 1982 Feb; 8(2):26-31. PubMed ID: 6279354
    [No Abstract]   [Full Text] [Related]  

  • 62. Anti-pseudomonas activity of azlocillin during pulmonary infection in patients with cystic fibrosis.
    Levy J; Baran D; Klastersky J
    J Antimicrob Chemother; 1982 Sep; 10(3):235-8. PubMed ID: 6815156
    [No Abstract]   [Full Text] [Related]  

  • 63. [Role of azlocillin in the treatment of immunocompromised patients. Results of the EORTC (European Organization for Research on the Treatment of Cancer) study)].
    Jacquillat C; Khayat D; Maral J
    Presse Med; 1984 Mar; 13(13):838-40. PubMed ID: 6324161
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Therapy of experimental Pseudomonas endocarditis with high-dose amikacin and ticarcillin.
    Choi C; Bayer AS; Fujita NK; Lam K; Guze LB; Yoshikawa TT
    Chemotherapy; 1983; 29(4):303-12. PubMed ID: 6872621
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Round table: optimal duration of antibiotic therapy in severe bacterial infections.
    Kirby WM; Turck M; Fleming PC; Hamburger M; Louria DB; Nelsen JD
    Antimicrob Agents Chemother (Bethesda); 1967; 7():183-202. PubMed ID: 5596140
    [No Abstract]   [Full Text] [Related]  

  • 66. Azlocillin compared with carbenicillin in the treatment of bronchopulmonary infection due to Pseudomonas aeruginosa in cystic fibrosis.
    Penketh A; Hodson ME; Gaya H; Batten JC
    Thorax; 1984 Apr; 39(4):299-304. PubMed ID: 6426075
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Randomized, double-blind evaluation of azlocillin for the treatment of pulmonary exacerbations of cystic fibrosis.
    McLaughlin FJ; Matthews WJ; Strieder DJ; Sullivan B; Goldmann DA
    J Antimicrob Chemother; 1983 May; 11 Suppl B():195-203. PubMed ID: 6352602
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Comparative efficacy and tolerance study of azlocillin and carbenicillin in patients with cystic fibrosis: a double blind study.
    Huang NN; Palmer J; Keith H; Schidlow D; Braverman S; Goldberg M
    J Antimicrob Chemother; 1983 May; 11 Suppl B():205-14. PubMed ID: 6352603
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Experiences using acylureido-penicillins (azlocillin, mezlocillin) in pediatrics].
    Weingärtner L; Sitka U; Patsch R; Thiemann HH
    Klin Padiatr; 1984; 196(1):28-35. PubMed ID: 6694339
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Treatment of pseudomonas infection with the new ureidopenicillin, azlocillin (author's transl)].
    Helm EB; Ristow W; Shah PM; Schacht P; Stille W
    Dtsch Med Wochenschr; 1977 Aug; 102(34):1211-6. PubMed ID: 913249
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Experiences with trimethoprim-sulfamethoxazole in the chemotherapy of bacterial infections].
    Tauchnitz C
    Z Gesamte Inn Med; 1970 Aug; 25(16):734-8. PubMed ID: 4941224
    [No Abstract]   [Full Text] [Related]  

  • 72. [Pharmacokinetics and clinical experience with 2 new penicillins: azlocillin and mezlocillin].
    Lode H; Niestrath K; Koeppe P; Langmaack H
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1704-6. PubMed ID: 347796
    [No Abstract]   [Full Text] [Related]  

  • 73. Azlocillin in cystic fibrosis.
    Malmborg AS; Alfredsson H; Strandvik B
    Isr J Med Sci; 1983 Nov; 19(11):1001-3. PubMed ID: 6662681
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Panel discussion of severe Gram-positive infections.
    Murdoch JM; Ronald A; Ishiyama S; Weinstein L
    Postgrad Med J; 1971 Feb; 47():Suppl:94-102. PubMed ID: 5556199
    [No Abstract]   [Full Text] [Related]  

  • 75. Mezlocillin and azlocillin: an evaluation of two new beta-lactam antibiotics.
    Ellis CJ; Geddes AM; Davey PG; Wise R; Andrews JM; Grimley RP
    J Antimicrob Chemother; 1979 Sep; 5(5):517-25. PubMed ID: 387705
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The penicillins.
    Barr NL
    Ear Nose Throat J; 1981 May; 60(5):215-8. PubMed ID: 6908856
    [No Abstract]   [Full Text] [Related]  

  • 77. Absence of a postantibiotic effect in experimental Pseudomonas endocarditis treated with imipenem, with or without gentamicin.
    Hessen MT; Pitsakis PG; Levison ME
    J Infect Dis; 1988 Sep; 158(3):542-8. PubMed ID: 3137272
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Treatment of serious gram-negative infections with aztreonam.
    Greenberg RN; Reilly PM; Luppen KL; McMillian R; Bollinger M; Wolk SM; Darji TB; Noorani AA
    J Infect Dis; 1984 Nov; 150(5):623-30. PubMed ID: 6541672
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Carbenicillin effect on Pseudomonas pyocyanea].
    Schaeper H
    Med Klin; 1969 Feb; 64(7):284-7. PubMed ID: 5192259
    [No Abstract]   [Full Text] [Related]  

  • 80. Successful treatment of osteomyelitis caused by Pseudomonas aeruginosa.
    Harding JW; Braddock GT; Croydon EA
    J Clin Pathol; 1970 Nov; 23(8):653-6. PubMed ID: 4992235
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.